PSA: Clinical Trials

1 active not recruiting, 1 terminated. 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	2	Active not recruiting 1, Terminated 1

Follow PSA: new trials by email Literature Review of PSA trials Research Report on PSA

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA Darolutamide, Radiotherapy - Advanced Prostate Carcinoma, Cancer of Prostate	Phase 2	Active not recruiting	Trans Tasman Radiation Oncology Group	65	2021-06-02	2025-08-21
OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone OGX-427, Abiraterone Acetate, Prednisone - Prostate Cancer, Metastatic Castrate-Resistant Prostate Cancer	Phase 2	Terminated	Costantine Albany	72	2012-12-01	2022-07-11

Narrower conditions

Prostatic Neoplasms (2)

Broader conditions

Genital Diseases (2)  ·  Genital Diseases, Male (2)  ·  Genital Neoplasms, Male (2)  ·  Male Urogenital Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Prostatic Diseases (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)

Interventions

Abiraterone Acetate (1)  ·  Prednisone (1)  ·  Radiotherapy (1)  ·  apatorsen (1)  ·  darolutamide (1)

Sponsors

Costantine Albany (1)  ·  Trans Tasman Radiation Oncology Group (1)

Countries

Australia (1)  ·  Canada (1)  ·  Singapore (1)  ·  United States (1)

Top investigators

Arun Azad (1)  ·  Constantine Albany, M.D. (1)  ·  Shankar Siva (1)